Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-transplant Cyclophosphamide in Haploidentical BMT for Hematologic Malignancies
NCT02623439Phase 2Terminated
- Sponsor
- University of California, San Diego
- Start
- Sep 2012
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in hematologic malignancy, sponsored by University of California, San Diego. Started Sep 2012; status: terminated.
02
Drugs
cyclophosphamide
03
Conditions
hematologic malignancy
Beyond the preview
Go deeper on NCT02623439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02623439.